Form 4: Thermo Fisher Scientific Director Acquires Additional Phantom Stock Units

Scott M. Sperling, a Director at Thermo Fisher Scientific Inc., has acquired 102.35 phantom stock units as part of the company's Deferred Compensation Plan for Directors.

Summary

• Scott M. Sperling, a Director of Thermo Fisher Scientific Inc. (TMO), acquired 102.35 phantom stock units on June 28, 2025.
• The acquisition was made at a price of $408.28 per unit, totaling approximately $41,794.98 in value for the acquired units.
• These units were credited to Sperling's account under the Issuer's Deferred Compensation Plan for Directors.
• Directors' retainers are deferred quarterly under this plan as Common Stock units, based on the closing price of the stock at quarter-end.
• The phantom stock units are convertible into Common Stock on a 1-for-1 basis.
• Following this transaction, Scott M. Sperling beneficially owns 17,337.12 phantom stock units.
• The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine compensation event, but the director's increasing stake, even through deferred compensation, can be viewed as a positive alignment of interests with shareholders.

Positives

• The acquisition of phantom stock units by a director aligns their interests with those of shareholders, as the value of these units is tied to the company's stock performance.
• The transaction is part of a structured deferred compensation plan, indicating a stable and predictable method of director remuneration.

Future Outlook

The phantom stock units are designed to be distributable as common stock upon the cessation of director service or a change of control, indicating a future conversion event tied to specific corporate or personal milestones.

Management Comments

• Phantom Stock Units were credited to the Reporting Person's account as of June 28, 2025, at a price of $408.28 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors.
• Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end.
• The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

Industry Context

The use of deferred compensation plans, including phantom stock units, is a common practice in corporate governance across various industries, particularly for non-employee directors. These plans aim to align the interests of directors with long-term shareholder value by tying a portion of their compensation to the company's stock performance.

Comparison to Industry Standards

• Deferred compensation plans for directors, often involving equity-linked instruments like phantom stock units, are a standard component of executive and director compensation packages in large publicly traded companies, including those in the life sciences and healthcare technology sectors like Thermo Fisher Scientific.
• This mechanism is comparable to similar plans at companies such as Danaher Corporation or Agilent Technologies, which also utilize equity-based compensation to incentivize long-term commitment and performance from their board members.

Corporate Governance

Related Party Transactions

• The acquisition of phantom stock units by Scott M. Sperling, a director, from Thermo Fisher Scientific Inc. is a related party transaction, specifically a compensation arrangement under the company's Deferred Compensation Plan for Directors.

Stakeholder Impact

• Shareholders: The transaction reinforces alignment between director interests and shareholder value, as the director's compensation is tied to the company's stock performance.
• Employees: No direct impact on employees is indicated by this specific filing.

Next Steps

• The phantom stock units will be converted into common stock and distributed upon the cessation of Scott M. Sperling's director service or in the event of a change of control at Thermo Fisher Scientific Inc.

Key Dates

Keywords

Thermo Fisher Scientific, TMO, Scott M. Sperling, Phantom Stock Units, Director Compensation, Deferred Compensation Plan, Insider Transaction, SEC Form 4, Corporate Governance